Meritxell Gonzalez Campos

Dr. Meritxell Gonzalez Campos

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GAGerard Anmella
Gerard Anmella
MPMichele De Prisco
Michele De Prisco
JJJeremiah Joyce
Jeremiah Joyce
CPClàudia Valenzuela Pascual
Clàudia Valenzuela Pascual
AMAriadna Mas-Musons
Ariadna Mas-Musons
Eduard VietaEduard Vieta
Eduard Vieta
Background: Bipolar disorder (BD) involves significant mood and energy shifts reflected in speech patterns. Detecting these patterns is crucial for diagnosis and monitoring, currently assessed subjectively. Advances in natural language processing offer opportunities to objectively analyze them. Aims: To (i) correlate speech features with manic-depressive symptom severity in BD, (ii) develop predictive models for diagnostic and treatment outcomes, and (iii) determine the most relevant speech features and tasks for these analyses. Methods: This naturalistic, observational study involved longitudinal audio recordings of BD patients at euthymia, during acute manic/depressive phases, and after-response. Patients participated in clinical evaluations, cognitive tasks, standard text readings, and storytelling. After automatic diarization and transcription, speech features, including acoustics, content, formal aspects, and emotionality, will be extracted. Statistical analyses will (i) correlate speech features with clinical scales, (ii) use lasso logistic regression to develop predictive models, and (iii) identify relevant speech features. Results: Audio recordings from 76 patients (24 manic, 21 depressed, 31 euthymic) were collected. The mean age was 46.0 ± 14.4 years, with 63.2% female. The mean YMRS score for manic patients was 22.9 ± 7.1, reducing to 5.3 ± 5.3 post-response. Depressed patients had a mean HDRS-17 score of 17.1 ± 4.4, decreasing to 3.3 ± 2.8 post-response. Euthymic patients had mean YMRS and HDRS-17 scores of 0.97 ± 1.4 and 3.9 ± 2.9, respectively. Following data pre-processing, including noise reduction and feature extraction, comprehensive statistical analyses will be conducted to explore correlations and develop predictive models. Conclusions: Automated speech analysis in BD could provide objective markers for psychopathological alterations, improving diagnosis, monitoring, and response prediction. This technology could identify subtle alterations, signaling early signs of relapse. Establishing standardized protocols is crucial for creating a global speech cohort, fostering collaboration, and advancing BD understanding.

18 June 2024 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
CPClàudia Valenzuela Pascual
Clàudia Valenzuela Pascual
AMAriadna Mas
Ariadna Mas
RBRoger Borràs
Roger Borràs
GAGerard Anmella
Gerard Anmella
MSMiriam Sanabra
Miriam Sanabra
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei

28 November 2024 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
MCMeritxell Gonzalez Campos
Meritxell Gonzalez Campos
HAHelena Andreu
Helena Andreu
OVOscar de Juan Viladegut
Oscar de Juan Viladegut
LOLuis Olivier
Luis Olivier
GAGerard Anmella
Gerard Anmella

21 August 2025 in Psychiatry Research
Verified
Journal Article
Open access
GDGiulia D'Alessandro
Giulia D'Alessandro
CSConstanza Sommerhoff
Constanza Sommerhoff
MBMarta Bort
Marta Bort
MPMichele De Prisco
Michele De Prisco
GFGiovanna Fico
Giovanna Fico
LMLaura Montejo
Laura Montejo
Cognitive Reserve (CR) has been proposed as a protective factor against cognitive decline and functional impairment in psychiatric disorders, including bipolar disorder (BD). However, how CR differs between BD, other psychiatric populations, and healthy individuals remains unclear. This systematic review and meta-analysis aimed to evaluate differences in CR between individuals with BD, healthy controls (HCs), at-risk populations, and patients with other psychiatric disorders. Following PRISMA guidelines, we systematically searched PubMed/MEDLINE, Scopus, PsycINFO, and Web of Science for studies assessing CR in BD and control populations, using validated CR measures or proxies (e.g., education, intelligence quotient, occupational status, leisure activities). A multilevel random-effects meta-analysis was performed to compare CR levels between BD and HCs, and BD and other psychiatric disorders. Twelve studies (N = 1861 participants) met inclusion criteria. Meta-analytic findings revealed that individuals with BD exhibited significantly lower CR than HCs (SMD = -0.45, 95 % CI: -0.69 to -0.20, I² = 84.5 %), whereas no significant differences emerged between BD and MDD (SMD = -0.23, 95 % CI: -0.49 to 0.03, I² = 41.7 %). Sociodemographic and clinical variables did not significantly moderate CR levels. CR is lower in BD compared to HCs, suggesting its contribution to cognitive and functional impairments. Conversely, similar CR between BD and MDD highlight shared clinical vulnerabilities. These results underscore the need for targeted interventions to enhance CR in patients with BD. Future research should prioritize standardized CR assessment and investigate modifiable factors contributing to CR development in psychiatric populations.

30 May 2026 in Psychiatry Research
Verified
Journal Article
Open access
NGNina Grabuleda
Nina Grabuleda
RBRoger Borràs
Roger Borràs
AMAnabel Martinez-Aran
Anabel Martinez-Aran
GAGerard Anmella
Gerard Anmella
NRNatalia Roberto
Natalia Roberto
ÍGÍria Grande
Íria Grande
Bipolar disorder (BD) is a prevalent, chronic and severe condition, with a high impact on psychosocial functioning. In the treatment of BD, maintenance therapy is crucial for preventing affective recurrences and long-term complications. The goal of this study was to conduct a descriptive analysis of the trajectories of pharmacological treatment along 20 years in a cohort of patients with BD, to better understand the diversity and changes in treatment patterns. This study analyses the prescription patterns of psychotropic medications and their association with clinical variables (sex, BD type, predominant polarity and psychotic symptoms) in a sample of 68 outpatients with BD (54.4% female, age of 39.31±12.04 at the start of the study) over a 20-year period. Maintenance therapy was predominantly based on combination strategies (75.8% at baseline). Our findings showed an increase in polypharmacy and benzodiazepines and a decline of mood stabilizers. This study offers insight into maintenance medication patterns among BD patients in a real-world setting over an extended period, revealing how prescribing tendencies have evolved. The widespread use of polypharmacy and benzodiazepines and the decrease in the prescription of mood stabilizers during the follow-up highlight a noticeable divergence between clinical practice and guideline recommendations.

4 November 2026 in JMIR Mental Health
Verified
Journal Article
Open access
CPClàudia Valenzuela Pascual
Clàudia Valenzuela Pascual
MGMarina Garriga
Marina Garriga
RBRoger Borràs
Roger Borràs
RVRuth Voltà-Solerdelcoll
Ruth Voltà-Solerdelcoll
MKMarta Korniyenko
Marta Korniyenko
DHDiego Hidalgo-Mazzei
Diego Hidalgo-Mazzei
Background: Although bipolar disorder (BD) lacks objective biomarkers of illness progression, wearable devices enable continuous, real-world collection of physiological digital biosignals, offering a promising approach to address this gap. Measures such as electrodermal activity (EDA) and heart rate variability (HRV) fluctuate with mood state and symptom severity. Previous studies have reported reduced EDA during depressive episodes and increased HRV following symptom resolution after acute mood episodes. Furthermore, greater illness burden in BD has been associated with lower HRV, suggesting that digital biosignals may capture not only state-related changes but also aspects of illness course. Objective: This study investigated whether naturalistic EDA and heart rate (HR) profiles differ according to illness course variables in BD—including diagnosis, predominant polarity, years since onset, and lifetime number of episodes—in euthymic patients, to evaluate their potential as illness course biomarkers. Methods: This cross-sectional post hoc analysis used data from 80 euthymic patients on the BD spectrum from the INTREPIBD-TIMEBASE cohort. Participants were recruited at Hospital Clínic de Barcelona (Spain) between 2021 and 2024 and wore an Empatica E4 wristband for 48 hours in naturalistic settings. Inclusion criteria comprised a current or past DSM-5 ( Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition) diagnosis of BD confirmed by structured interview and sustained euthymia. We examined the effects of 4 illness course variables (diagnosis, predominant polarity, years since onset, and number of lifetime episodes) on 3 biosignals (mean EDA, EDA peaks per minute, and HR) using generalized additive models. Interactions between illness course variables and circadian patterns were also assessed. All models were adjusted for age, sex, and current antipsychotic use and included a participant-specific random effect. Results: Of the 80 participants, 49 (61.3%) were female; participants’ mean age was 46.9 (SD 14.1) years. After adjustment for covariates and multiple comparisons, no significant associations were observed between illness course variables and EDA or HR. In sensitivity analyses excluding patients with schizoaffective disorder (n=75), years since illness onset and predominant polarity were associated with EDA peaks per minute after multiple comparison correction. Specifically, patients with more than 22 years since illness onset had fewer EDA peaks compared with other groups (β=−1.06, 95% CI −1.71 to −0.41; P =.001). No significant interactions were found between illness course variables and circadian patterns of EDA or HR. Conclusions: To our knowledge, this is the first study to examine the association between illness course variables and EDA and HR recorded in naturalistic settings in BD. In contrast to prior findings linking illness burden with HRV, our results suggest that years since illness onset may show modest associations with phasic EDA activity. These findings indicate that digital biosignals may be more sensitive to state-related changes than to illness course characteristics, limiting their use as longitudinal biomarkers of disease progression.